Henry Schein Inc (HSIC) delivered better-than-expected financial results for the third quarter of fiscal 2025. The company reported earnings per share (EPS) of $1.38, surpassing Wall Street's consensus estimate of $1.30 by $0.08. Revenue matched expectations at $3.3 billion.
The results reflect the company's robust operational performance amid a competitive landscape. With a market capitalization of $8,347.87 million and a price-to-earnings (P/E) ratio of 21.46, Henry Schein operates in the health care sector, providing a wide array of products and services to medical, dental, and veterinary practitioners. Headquartered in Melville, New York, the company employs approximately 25,000 full-time staff and is structured into segments that include Global Distribution and Value-Added Services, Global Specialty Services, and Global Technology.
Henry Schein will host an earnings conference call to discuss these results and offer further insights into business performance. Investors should review the complete earnings release and management commentary for a comprehensive understanding of the quarter's achievements and future outlook. Upcoming earnings are scheduled for May 3, 2026, with an estimated EPS of 1.2926 and revenue expectations of $3.4 billion.
This update provides insight into Henry Schein Inc's financial health and operational strength, underscoring the company's ability to exceed analyst expectations.